Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer (NY: PFE ) 28.09 -0.21 (-0.74%) Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pfizer < Previous 1 2 3 4 5 6 7 8 9 ... 99 100 Next > Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade October 14, 2024 The analyst is closely watching MariTide, a potential monthly injection to treat obesity. Via Investor's Business Daily Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly? October 14, 2024 These two stocks will appeal to very different types of investors at the moment. Via The Motley Fool FDA Approves Pfizer's Second Hemophilia Drug With Six Months October 14, 2024 Pfizer's Hympavzi receives FDA approval as the first anti-TFPI therapy for hemophilia A and B. This subcutaneous, once-weekly treatment reduces bleeding rates and offers convenience via an... Via Benzinga Exposures Product Safety Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade October 14, 2024 Buying these stocks gives you a great chance to beat the benchmark. Via The Motley Fool Topics Stocks Exposures US Equities 2 Unstoppable Growth Stocks to Buy Right Now for Less than $200 October 12, 2024 These businesses are trading at discounts right now. Via The Motley Fool Pfizer’s Seasonal Strength And Starboard’s Activist Move October 11, 2024 Starboard's involvement signals frustration over Pfizer’s recent setbacks, including costly acquisitions that haven’t delivered expected returns. Via Talk Markets (PFE) - Analyzing Pfizer's Short Interest October 11, 2024 Via Benzinga 2 Incredibly Cheap Big Pharma Stocks to Buy Now October 12, 2024 There's doubtlessly some coming uncertainty for both, but the prices are right. Via The Motley Fool 3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right Now October 12, 2024 You don't need to be rich to put your money to work on Wall Street. Via The Motley Fool Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names October 11, 2024 The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns. Via Benzinga U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors October 11, 2024 From Pfizer Inc. Via Business Wire Stock Market Rallies As S&P 500, Dow Hit Highs; Tesla Robotaxi Isn't Hailed, Delta, JPMorgan In Focus: Weekly Review October 11, 2024 A number of leading stocks flashed buy signals over the past week. Via Investor's Business Daily Topics Stocks Exposures US Equities An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock October 11, 2024 There may be changes coming to this company, if the activists get their way. Via The Motley Fool Why Pfizer Stock Tumbled by Nearly 3% on Thursday October 10, 2024 The company's latest institutional shareholder has made some troubling allegations against it. Via The Motley Fool GSK, Pfizer Face Declining Respiratory Syncytial Virus Vaccine Sales Due To Narrow Age Recommendations October 10, 2024 RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age group and reducing demand by two-thirds compared to last year. Via Benzinga Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer October 10, 2024 On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The large-scale clinical project assessed how personalized cancer therapies could... Via Benzinga What's Going On With Pfizer Stock On Thursday? October 10, 2024 Starboard Value engages with Pfizer's leadership amid growing concerns over the company's trajectory. Meanwhile, Pfizer reports a significant survival benefit in prostate cancer patients from its... Via Benzinga Pfizer Skids After Former Execs Flip On Activist Investor, Siding With CEO Albert Bourla October 10, 2024 Ian Read and Frank D'Amelio say they are now "fully supportive" of CEO Albert Bourla. Via Investor's Business Daily Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial October 10, 2024 From Pfizer Inc. Via Business Wire 2 No-Brainer Healthcare Stocks to Buy With $200 Right Now October 10, 2024 Both of these stocks should have plenty of room to run. Via The Motley Fool Former Pfizer Executives Ian Read And Frank D'Amelio Support Albert Bourla's Leadership Amid Starboard Activism: 'Will Deliver Shareholder Value' October 09, 2024 Former Pfizer Inc CEO Ian Read and ex-CFO Frank D'Amelio have decided to distance themselves from the activist campaign led by Starboard Value at the pharmaceutical giant. Via Benzinga Why Pfizer Stock Popped Today October 09, 2024 The sharp, sudden entry of an activist investor is raising hopes that change might come to the company. Via The Motley Fool Pfizer Declares Fourth-Quarter 2024 Dividend October 09, 2024 From Pfizer Inc. Via Business Wire Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients October 09, 2024 The Biden administration's proposed Medicare $2 Drug List Model aims to provide low-cost generic drugs for seniors and people with disabilities, with copayments capped at $2 per month for essential... Via Benzinga S&P 500 Hits New All-Time High Ahead Of Fed Minutes As Lower Oil Prices Offer Relief: What's Driving Markets Wednesday? October 09, 2024 The S&P 500 climbed 0.5% during morning trading in New York, reaching a new all-time high by surpassing the 5,770 level, previously touched in late September. Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Billionaire Ken Griffin Just Bought 7.9 Million Shares of This Beaten-Down Pharmaceutical Stock as It Eyes the Weight Loss Market October 09, 2024 Ken Griffin's Citadel continues to add to its position in Pfizer. Via The Motley Fool These 3 Stocks Just Spiked—Buy the Rally or Sell the News? October 09, 2024 Investors received news about three stocks that moved each stock higher, but now investors have to decide whether to buy the rally or take some profits Via MarketBeat As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock? October 09, 2024 Starboard will look to turn around the struggling pharma company. Via The Motley Fool Pfizer CEO Albert Bourla Set To Meet Activist Investor Starboard Value As Pressure Mounts To Revitalize Struggling Stock: Report October 08, 2024 Pfizer Inc. CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the pharmaceutical giant's struggling share price and refine its strategic focus.... Via Benzinga Pfizer to Showcase Scientific Advancements in Respiratory and Other Infectious Diseases at IDWeek 2024 October 08, 2024 From Pfizer Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 99 100 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
